Pharmacogenomics
2019 · The Lancet · 389 citations
https://doi.org/10.1016/s0140-6736(19)31276-0
S
Sara L. Van Driest
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
182
Papers
7.2K
Citations
43
h-index
103
i10-index
Sara L. Van Driest is an academic researcher from PragmatIC (United Kingdom). The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Pharmaceutical studies and practices & Cardiomyopathy and Myosin Studies. The author has an h-index of 43, co-authored 155 publications.
ORCID: 0000-0003-2580-1405Papers by this author
worksClinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy
2021 · Clinical Pharmacology & Therapeutics · 366 citations
https://doi.org/10.1002/cpt.2149
Moving Pharmacogenetics Into Practice: It’s All About the Evidence!
2021 · Clinical Pharmacology & Therapeutics · 66 citations
https://doi.org/10.1002/cpt.2327
Developing an Algorithm to Detect Early Childhood Obesity in Two Tertiary Pediatric Medical Centers
2016 · Applied Clinical Informatics · 63 citations
https://doi.org/10.4338/aci-2016-01-ra-0015
Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network
2021 · Genetics in Medicine · 32 citations
https://doi.org/10.1038/s41436-021-01118-9
Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network
2021 · Genetics in Medicine · 32 citations
https://doi.org/10.1038/s41436-021-01118-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat